… The origins of exogenous surfactant therapy lie in the discovery … the basics as they relate
to exogenous surfactant therapy. … to overcome current and future therapeutic challenges. …

… relate to the potential of exogenous surfactant therapy for COVID-19 … exogenous surfactant
administration remains primarily directed by trial and error and needs to be optimized in future …

… surfactant with protein components. • In preterm infants with respiratory distress syndrome,
administration of exogenous surfactant therapy … consensus opinion for future research steps. …

… the most promising aims for future development. Scientists have … Administration of exogenous
surfactant to preterm infants … , surfactant therapy has become the standard therapy of …

… exogenous surfactant therapy in these infants. Finally, we argue that less invasive modes of
surfactant administration … approach in combining CPAP/NIV and early surfactant. Beneficial …

… future development of optimal surfactant delivery techniques and … exogenous surfactant
therapy in severe lung diseases. A clinical trial on exogenous surfactant administration therapy (…

… the future, we can imagine an even more individualized therapy … type: the surfactant adsorption
test [63,64,65] and the surfactant … In time, our knowledge about exogenous surfactant has …

… While it is possible to claim that exogenous surfactant is an ineffective treatment strategy
for … (1) Which patients require surfactant therapy and what type of surfactant is indicated? (2) …

… Surfactant administration did not cause acute decompensation… This study supports the future
performance of randomized … Thus, our data suggest that exogenous surfactant installation …

… COVID-19 causes lung damage and ARDS, so beneficial effects of surfactant therapy in
COVID-19-associated ARDS patients are conceivable, especially when applied early in the …